Abdo-Francis JM, Martínez-Juárez A, Pineda-Corona B, Bernal-Sahagún F

Language: Spanish
References: 10
Page: 142-146
PDF size: 84.20 Kb.

ABSTRACT

Introduction: Abdominal colic pain is a common cause of gastrointestinal consultation. Several drugs have been employed for its treatment. Aim of the study: To evaluate a combination of a new triphenol (1,3,5 trihidroxibenceno and 1,3,5 trimetoxibenceno) plus lisine clonixilate drug with antispasmodic and analgesic properties in comparison with butilhioscine plus metamizol. Material and methods: We made a multicentric, open, prospective, comparative study in 205 patients with abdominal pain without intestinal occlusion or subocclusion. Results: Our results show that both drugs provide abdominal pain relief with similar efficacy. There were not statistical differences between them. The doses needed of triphenol plus lisine clonixilate were less in comparison with butilhioscine plus metamizol. Conclusion: The combination of triphenol (1,3,5 trihidrocibenceno and 1,3,5 trimetoxibenceno) plus lisine clonixilate drug is a new therapeutical option in the management of abdominal pain.

REFERENCES

1. Mac-Bryde. Signos y síntomas. Fisiopatología aplicada e interpretación clínica. 5a ed. México: Interamericana, 1986; 44-47.

2. Goodman y Gilman. Las bases farmacológicas de la terapéutica. 6a ed. México: Interamericana, 1981; 132-149.

3. Bustamante D et al. Effects of intrathecal or intracerebroventricular administration of non-steroidal anti-inflammatory drugs on a C-fiber reflex in rats. J Pharmacol Exper Therap 1997; 281: 1381-1391.

4. Kramer E et al. Acción del clonixinato de lisina sobre la función plaquetaria. Comparación con otras drogas antiinflamatorias no esteroideas. Medicina (Buenos Aires) 2000; 60: 301-307.

5. Peña H et al. Ensayo clínico terapéutico con el analgésico clonixinato de lisina. IMI 1996; 75: 200-203.

6. Paredes B, Solis R, Palacios J. The use of intravenous clonixilate for rapid pain relief. An open clinical study. Therap Res 1986; 40: 86-91.

7. Debray C, Hardouin J. Primer empleo terapéutico del floroglucinol. Therapie 1961; 16: 978-990.

8. Carrillo G et al. Estudio de la eficacia de los trifenoles y el piroxicam en la dismenorrea. IMI 1993; 19: 3.

9. Dollo G et al. Biodisponibilité du phoroglucinol chez l home. J Pharm Belg 1999; 54: 75-82.

10. Abdo F et al. Estudio clínico sobre eficacia y seguridad del 1,3,5 trihidroxibenceno y del 1,3,5 trimetoxibenceno (trifenoles) comparado con butilhioscina en el alivio del dolor cólico de origen intestinal. IMI 1998; 24: 65-71.